Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Genky DrugStores Co., Ltd. ( (JP:9267) ) is now available.
Genky DrugStores reported that in January of the fiscal year ending June 2026, total net sales across all stores rose 5.7% year on year, while existing-store sales dipped 1.4%, reflecting flat customer traffic and a decline in spending per customer. The chain continued its expansion, opening one new standardized regular store and ending the month with 500 outlets in total, with year-to-date figures showing double‑digit growth in all-store sales driven largely by new store openings, even as like-for-like sales growth moderated, underscoring the company’s reliance on network expansion and store standardization to sustain overall top-line growth.
The most recent analyst rating on (JP:9267) stock is a Buy with a Yen4934.00 price target. To see the full list of analyst forecasts on Genky DrugStores Co., Ltd. stock, see the JP:9267 Stock Forecast page.
More about Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd., listed on the Tokyo Stock Exchange Prime Market, operates a chain of drugstores that sell pharmaceuticals, daily necessities and related products through a standardized 300-tsubo (about 999 m²) regular-store format. The company is pushing a strategy of store standardization, including refurbishing larger and other non-standard outlets into its regular-store model, while steadily expanding its national network of drugstores.
Average Trading Volume: 95,093
Technical Sentiment Signal: Buy
Current Market Cap: Yen138.2B
For an in-depth examination of 9267 stock, go to TipRanks’ Overview page.